News|Articles|July 6, 2026

4 Gastroenterology Headlines You Missed in June 2026

Fact checked by: Victoria Johnson

Catch up on phase 3 data for tulisokibart and obefazimod, expert perspective on linaclotide's expanded FDA approval, and more.

June brought continued momentum in gastroenterology, with late-stage clinical trial successes in ulcerative colitis, expanded treatment options for pediatric patients, and expert insights into the diagnosis of complex gastrointestinal disorders. Together, the month's developments highlighted ongoing innovation in inflammatory bowel disease while reinforcing the importance of timely recognition and multidisciplinary management across the spectrum of GI care.